Levin Capital Strategies, L.P. Biogen Inc. Transaction History

Levin Capital Strategies, L.P.

$952 Million
Q2 2024

A detailed history of Levin Capital Strategies, L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 2,226 shares of BIIB stock, worth $443,775. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,226

Previous 9,218 75.85%

Holding current value

$443,775

Previous $1.99 Million 74.03%

% of portfolio

0.05%

Previous 0.2%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$190.52 - $236.72 $1.33 Million - $1.66 Million	-6,992 Reduced 75.85%	2,226 $516,000
Q1 2024 May 16, 2024	BUY	$212.02 - $267.71 $1.95 Million - $2.47 Million	9,218 New	9,218 $1.99 Million
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $96,337 - $111,321	-350 Reduced 20.98%	1,318 $375,000
Q1 2023 Apr 24, 2023	SELL	$256.56 - $292.34 $37,457 - $42,681	-146 Reduced 8.05%	1,668 $463,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $291,061 - $401,347	-1,495 Reduced 45.18%	1,814 $484,000
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $19,377 - $24,414	-100 Reduced 2.93%	3,309 $697,000
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $882,931 - $1.41 Million	-3,409 Reduced 50.0%	3,409 $1.18 Million
Q1 2021 May 05, 2021	SELL	$242.95 - $284.63 $145,770 - $170,778	-600 Reduced 8.09%	6,818 $1.91 Million
Q3 2020 Nov 17, 2020	BUY	$264.77 - $305.71 $977,001 - $1.13 Million	3,690 Added 98.98%	7,418 $2.1 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1.05 Million - $1.23 Million	3,728	3,728 $1.17 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account

Levin Capital Strategies, L.P. Biogen Inc. Transaction History